CAS | 1007306-20-8 |
Sequence | Abz-Val-Asn-Leu-Asp-Ala-Glu-EDDnp |
Sequence Single | Abz-VNLDAE-EDDnp |
Molecular Formula | C42H58N12O16 |
Molecular Weight | 986.99 |
Synonyms | JMV2236, Abz-(Asn670,Leu671)-APP770 (669-674)-EDDnp |
Technology | Synthetic |
Storage | -20°C, avoid light, cool and dry place |
Application | Alzheimer’s Disease |
Description | Abz-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (669-674)-EDDnp also called JMV2236, Abz-(Asn670,Leu671)-APP770 (669-674)-EDDnp, is a intramolecularly quenched fluorescent substrate containing the ortho-aminobenzoyl (Abz) / N-(2,4-dinitrophenyl)ethylenediamine (EDDnp) groups as the donor / acceptor pair. It corresponds to the Swedish-mutated (JMV2236) β-amyloid precursor protein (βAPP) sequence targeted by β-secretase BACE (β-site APP-cleaving activity). This FRET substrate is more selectively cleaved by BACE1 and BACE2 than by cathepsin D, a disintegrin and metalloprotease 10 (ADAM10), tumor necrosis α-converting enzyme (TACE), presenilin-1 (PS1), or presenilin-2 (PS2). |
References | 1. BACE1- and BACE2-expressing human cells: characterization of beta-amyloid precursor protein-derived catabolites, design of a novel fluorimetric assay, and identification of new in vitro inhibitors. D.Andrau et al., J. Biol. Chem., 278, 25859 (2003) |